Heron Therapeutics (HRTX) EV to EBITDA (2011 - 2026)
Heron Therapeutics' (HRTX) quarterly EV to EBITDA came in at 19.07 in Q2 2026, up 88.72% on a YoY basis from 10.1 in Q2 2025, and up 14.8% quarter-over-quarter from 22.38 in Q1 2026.
Powered by 
Analysis
Heron Therapeutics (HRTX) EV to EBITDA (2011 - 2026) Analysis & Trends
Heron Therapeutics (HRTX) has reported EV to EBITDA for 16 consecutive years, with 19.07 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EV to EBITDA rose 88.72% year-over-year to 19.07; the trailing twelve-month figure through Jun 2026 stood at 3.59 (down 101.6% YoY), and the FY2025 full-year result was 78.08, down 418.9% from the prior year.
- EV to EBITDA improved to 19.07 in Q2 2026 per HRTX's latest filing, from 22.38 in the prior quarter.
- Across five years, EV to EBITDA topped out at 5215.2 in Q4 2025 and bottomed at 169.02 in Q2 2025.
- Historically, EV to EBITDA has averaged 268.87 across 5 years, with a median of 9.77 in 2022.
- The sharpest annual moves came in 2024 and 2025: EV to EBITDA sank 2245.03% in 2024, then surged 12445.52% in 2025.
- Over 5 years, EV to EBITDA stood at 10.47 in 2022, then tumbled by 63.68% to 17.13 in 2023, then jumped by 342.67% to 41.57 in 2024, then soared by 12445.52% to 5215.2 in 2025, then sank by 100.37% to 19.07 in 2026.
- According to Business Quant data, EV to EBITDA over the past three periods registered 19.07, 22.38, and 5215.2 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn |
| 10 | Heron Therapeutics | 64.55 Mn | 21.89 Mn | 26.09 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -19.07 |
| Mar 31, 2026 | -22.38 |
| Dec 31, 2025 | 5,215.20 |
| Sep 30, 2025 | -42.89 |
| Jun 30, 2025 | -169.02 |
| Mar 31, 2025 | 90.35 |
| Dec 31, 2024 | 41.57 |
| Sep 30, 2024 | -51.99 |
| Jun 30, 2024 | -71.91 |
| Mar 31, 2024 | -72.07 |
| Dec 31, 2023 | -17.13 |
| Sep 30, 2023 | -3.10 |
| Jun 30, 2023 | -3.07 |
| Mar 31, 2023 | -3.65 |
| Dec 31, 2022 | -10.47 |
| Sep 30, 2022 | -9.07 |
| Jun 30, 2022 | -4.10 |
| Mar 31, 2022 | -7.54 |
| Dec 31, 2021 | -14.45 |
| Sep 30, 2021 | -17.15 |